Insider Trading & Executive Data
Start Free Trial
179 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
UiPath is an enterprise software company focused on automation and AI-native capabilities built on its RPA heritage; its UiPath Platform combines UI/API automation, IDP, process mining, low-code development, automated testing and embedded AI to target enterprise, mid-market and SMB customers globally. The company is transitioning customers toward SaaS/Flex offerings (subscription ARR was a key growth driver) while investing heavily in agentic automation and AI R&D, completing small M&A (e.g., Peak) and maintaining strategic hyperscaler partnerships. Fiscal 2025 revenue was $1.43B (up 9% Y/Y), ARR was roughly $1.66B (14% Y/Y) with subsequent Q1 ARR of $1.72B; management highlights customer expansion as the primary growth engine even as dollar-based net retention eased.
Given UiPath’s SaaS transition and AI investment priorities, compensation programs are likely weighted toward long-term, equity-based incentives that align executives to ARR growth, dollar-based net retention, in‑account expansion and product milestones (agentic automation adoption), rather than short‑term license sales. Management commentary and the company’s heavy R&D and restructuring activity point to continued use of stock awards and performance vesting tied to subscription metrics and margin/cost-control objectives; reductions in stock‑based compensation following workforce actions suggest adjustments to pay mix can be used to manage operating loss targets. Material operating cash flow and a sizable share‑repurchase program also mean cash bonuses and NEAT (non‑equity) components may supplement equity grants, while ASC 606 judgment items and ARR timing can influence bonus payouts and performance measurement windows.
Insiders at UiPath will frequently hold significant equity exposure because of stock‑heavy compensation, so periodic sales for diversification are common — expect disclosures around scheduled Rule 10b5‑1 plans and occasional open‑market sales concurrent with large buyback activity. The company’s active repurchase program ($390.8M repurchased in FY25, ~$329.1M YTD with roughly $507M remaining under a $1B authorization) can compress float and move per‑share metrics, so insider transactions near buyback announcements or earnings that update ARR/retention trends merit close scrutiny. Regulatory and operational dynamics (data privacy, EU AI Act, hosting purchase commitments and ASC 606 allocation) create event risk that could trigger opportunistic insider trades around restructuring completions, major product releases, or M&A — monitor blackout windows, 10b5‑1 plan start/end dates and patterns of sales following vesting events.